Pharmaceutical

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in...

Oracle Enhances Electronic Data Capture Solution to Streamline Clinical Trials and Help Bring New Therapies to Market Faster

Updates include AI-enabled EHR interoperability, comprehensive data collection, and safety integration capabilities AUSTIN, Texas, Aug. 27, 2025 /PRNewswire/ -- Oracle today...

error: Content is protected !!